Di Gao; Gengli Zhao; Xueyin Wang; Juan Juan; Yupeng Shi; Taoye Xu; Yue Wang; Linhong Wang; Xiaosong Zhang; Di Gao; Gengli Zhao; Xueyin Wang; Juan Juan; Yupeng Shi; Taoye Xu; Yue Wang; Linhong Wang; Xiaosong Zhang

doi:10.46234/ccdcw2025.053

[1]

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74(3):229 − 63. https://doi.org/10.3322/caac.21834.

[2]

Sun KX, Han BF, Zeng HM, Wang SM, Li L, Chen R, et al. Incidence and mortality of cancers in female genital organs - China, 2022. China CDC Wkly 2024;6(10):195 − 202. https://doi.org/10.46234/ccdcw2024.040.

[3]

Zhu B, Liu YY, Zuo TT, Cui XL, Li MD, Zhang J, et al. The prevalence, trends, and geographical distribution of human papillomavirus infection in China: the pooled analysis of 1. 7 million women. Cancer Med 2019;8(11):5373 − 85. https://doi.org/10.1002/cam4.2017.

[4]

Hu XH, Meng L, Gao YX, Man SLM, Ma Y, Jin C, et al. Characteristics of human papillomavirus infection and abnormal cervical cytology in health check-up females in Shenzhen. Chin J Epidemiol 2021;42(7):1205 − 12. https://doi.org/10.3760/cma.j.cn112338-20210106-00007.

[5]

Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009;4:8. https://doi.org/10.1186/1750-9378-4-8.

[6]

Della Fera AN, Warburton A, Coursey TL, Khurana S, McBride AA. Persistent human papillomavirus infection. Viruses 2021;13(2):321. https://doi.org/10.3390/v13020321.

[7]

Bao HL, Jin C, Wang S, Song Y, Xu ZY, Yan XJ, et al. Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: a nationwide population-based study. J Infect 2021;82(4):75 − 83. https://doi.org/10.1016/j.jinf.2021.02.017.

[8]

de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007;7(7):453 − 9. https://doi.org/10.1016/S1473-3099(07)70158-5.

[9]

Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA 2023;330(6):547 − 58. https://doi.org/10.1001/jama.2023.13174.

[10]

Wei FX, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 2024;404(10451):435 − 44. https://doi.org/10.1016/S0140-6736(24)01097-3.